Literature DB >> 2649884

Transfer of the inducible lac repressor/operator system from Escherichia coli to a vaccinia virus expression vector.

T R Fuerst1, M P Fernandez, B Moss.   

Abstract

Cis- and trans-acting elements of the Escherichia coli lac operon were transferred to vaccinia virus and used to regulate gene expression. A recombinant virus that constitutively expresses a modified lac repressor gene (lacI) was constructed. We calculated that each infected cell contained approximately 2 x 10(7) active repressor molecules (and 1-2 x 10(4) copies of the vaccinia virus genome). A strong vaccinia-virus late promoter was modified by insertion of the lac operator (lacO) at various positions. The ability of each modified promoter to regulate expression of beta-galactosidase was tested by transient assays in cells infected with wild-type or lacI-containing vaccinia virus. Placement of the lacO just downstream of the conserved TAAAT sequence of a late promoter was consistent with a minimal effect on basal expression and good repressibility, whereas basal expression was severely inhibited when lacO overlapped or preceded the TAAAT motif. A single recombinant vaccinia virus containing lacI and the beta-galactosidase gene under control of the optimal lacO promoter was constructed. In the absence of inducer, cells infected with this double recombinant virus synthesized little or no detectable beta-galactosidase. Addition of isopropyl beta-D-thiogalactoside restored expression to greater than 20% of the unrepressed level. This inducible vector system has potential applications for expression of heterologous and homologous genes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649884      PMCID: PMC286954          DOI: 10.1073/pnas.86.8.2549

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 2.  Vaccinia virus expression vectors.

Authors:  B Moss; C Flexner
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

3.  lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells.

Authors:  M Brown; J Figge; U Hansen; C Wright; K T Jeang; G Khoury; D M Livingston; T M Roberts
Journal:  Cell       Date:  1987-06-05       Impact factor: 41.582

4.  The inducible lac operator-repressor system is functional in mammalian cells.

Authors:  M C Hu; N Davidson
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

5.  Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment.

Authors:  J L Rosel; P L Earl; J P Weir; B Moss
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

6.  Determination of the transcriptional regulatory region of a vaccinia virus late gene.

Authors:  J P Weir; B Moss
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

7.  Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes.

Authors:  T R Fuerst; P L Earl; B Moss
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

8.  Purification and characterization of a transcription termination factor from vaccinia virions.

Authors:  S Shuman; S S Broyles; B Moss
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

9.  Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.

Authors:  S Chakrabarti; K Brechling; B Moss
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  Functional analysis of the 5' flanking sequence of a vaccinia virus late gene.

Authors:  C Bertholet; P Stocco; E Van Meir; R Wittek
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

View more
  33 in total

1.  Recombinant vaccinia viruses. Design, generation, and isolation.

Authors:  C C Broder; P L Earl
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

2.  The A20R protein is a stoichiometric component of the processive form of vaccinia virus DNA polymerase.

Authors:  N Klemperer; W McDonald; K Boyle; B Unger; P Traktman
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases.

Authors:  G L Smith; Y S Chan; S M Kerr
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

4.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress.

Authors:  J F Rodriguez; G L Smith
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

6.  Inducer-dependent conditional-lethal mutant animal viruses.

Authors:  Y F Zhang; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

7.  Inducible gene expression from African swine fever virus recombinants: analysis of the major capsid protein p72.

Authors:  R García-Escudero; G Andrés; F Almazán; E Viñuela
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.

Authors:  R L Roper; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

9.  Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.

Authors:  J E Jewell; L A Ball; R Rueckert
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

10.  DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles.

Authors:  M C Cassetti; M Merchlinsky; E J Wolffe; A S Weisberg; B Moss
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.